Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level

European Journal of Immunology

Volumn 35, Issue 6, 2005, Pages 1681-1691

  Roncador, Giovanna ^a   Brown, Philip J ^b   Maestre, Lorena ^a   Hue, Sophie ^c   Martínez Torrecuadrada, Jorge L ^a   Ling, Khoon Lin ^a   Pratap, Sarah ^d   Toms, Christy ^c   Fox, Bridget C ^b   Cerundolo, Vincenzo ^d   Powrie, Fiona ^c   Banham, Alison H ^b  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

FOXP3; Lymphoma; Monoclonal antibody; Regulatory T cell

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; LYMPHOCYTE SURFACE MARKER; MONOCLONAL ANTIBODY; TRANSCRIPTION FACTOR FOXP3;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CLONE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LYMPHOCYTE FUNCTION; MEDICAL RESEARCH; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIBODIES, MONOCLONAL; CROSS REACTIONS; DNA-BINDING PROTEINS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES, REGULATORY;

EID: 20844432429     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200526189     Document Type: Article

References (58)

1. Chatila, T. A., Blaeser, F., Ho, N., Lederman, H. M., Voulgaropoulos, C., Helms, C. and Bowcock, A. M., JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin. Invest. 2000. 106: R75-R81.
2. Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F. and Ochs, H. D., The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 2001. 27: 20-21.
3. Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A., Paeper, B., Clark, L. B., Yasayko, S.-A., Wilkinson, J. E., Galas, D., Ziegler, S. F. and Ramsdell F., Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 2001. 27: 68-73.
4. Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L. et al., X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 2001. 27: 18-20.
5. Godfrey, V. L., Wilkinson, J. E. and Russell, L. B., X-linked lymphoreticular disease in the scurfy (sf) mutant mouse. Am. J. Pathol. 1991. 138: 1379-1387.
6. - T cells are the effector cells in disease pathogenesis in the scurfy (sf) mouse. J. Immunol. 1994. 153: 3764-3774.
7. Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A. and Sharpe, A. H., Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995. 3: 541-547.
8. Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesses, H. and Mak, T. W., Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 1995. 270: 985-988.
9. Khattri, R., Kasprowicz, D., Cox, T., Mortrud, M., Appleby, M. W., Brunkow, M. E., Ziegler, S. F. and Ramsdell, F., The amount of scurfin protein determines peripheral T cell number and responsiveness. J. Immunol. 2001. 167: 6312-6320.
10. Schubert, L. A., Jeffery, E., Zhang, Y., Ramsdell, F. and Ziegler, S. F., Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J. Biol. Chem. 2001. 276: 37672-37679.
11. Fontenot, J. D., Gavin, M. A. and Rudensky, A. Y., Foxp3 programs the development and function of CD4(+)CD25(+) regulatory T cells. Nat. Immunol. 2003. 4: 330-336.
12. Hori, S., Nomura, T. and Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003. 299: 1057-1061.
13. + T regulatory cells. Nat. Immunol. 2003. 4: 337-342.
14. Maloy, K. J. and Powrie, F., Regulatory T cells in the control of immune pathology. Nat. Immunol. 2001. 2: 816-822.
15. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 2001. 182: 18-32.
16. + T cells. Curr. Opin. Immunol. 2003. 15: 690-696.
17. + immunoregulatory T cells: central players in the arena of peripheral tolerance. Semin. Immunol. 2004. 16: 81-88.
18. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 1998. 188: 287-296.
19. + T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 2001. 193: 1285-1294.
20. + immunoregulatory cells. J. Immunol. 2001. 167: 1137-1140.
21. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. and Toda, M., Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995. 155: 1151-1164.
22. + regulatory T cells that control intestinal inflammation. J. Exp. Med. 2000. 192: 295-302.
23. + regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 2004. 199: 971-979.
24. Hara, M., Kingsley, C. I., Niimi, M., Read, S., Turvey, S. E., Bushell, A. R., Morris, P. J., Powrie, F. and Wood, K. J., IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. 2001. 166: 3789-3796.
25. + immunoregulatory T cells: new therapeutics for graft-versus-host disease. J. Exp. Med. 2002. 196: 401-406.
26. + regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J. Exp. Med. 2002. 196: 389-399.
27. + immune regulatory cells inhibits graft-versus-host disease lethality. Blood 2002. 99: 3493-3499.
28. Curotto de Lafaille, M. A., Muriglan, S., Sunshine, M. J., Lei, Y., Kutchukhidze, N., Furtado, G. C., Wensky, A. K., Olivares-Liaalgomez, D. and Lafaille, J. J., Hyper immunolglobulin E response in mice with monoclonal populations of B and T lymphocytes. J. Exp. Med. 2001. 194: 1349-1359.
29. + regulatory T cells control Leishmania major persistence and immunity. Nature 2002. 420: 502-507.
30. Woo, E. Y., Chu, C. S., Goletz, T. J., Schlienger, K., Yeh, H., Coukos, G., Rubin, S. C., Kaiser, L. R. and June, C. H., Cutting edge: regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J. Immunol. 2002. 168: 4272-4276.
31. Liyanage, U. K., Moore, T. T., Joo, H. G., Tanaka, Y., Herrmann, V., Doherty, G., Drebin, J. A., Strasberg, S. M., Eberlein, T. J., Goedegebuure, P. S. and Linehan, D. C., Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J. Immunol. 2002. 169: 2756-2761.
32. Wolf, A. M., Wolf, D., Steurer, M., Gastl, G., Gunsilius, E. and Grubeck-Loebenstein, B., Increase of regulatory T cells in the peripheral blood of cancer patients. Clin. Cancer Res. 2003. 9: 606-612.
33. Marshall, N. A., Christie, L. E., Munro, L. R., Culligan, D. J., Johnston, P. W., Barker, R. N. and Vickers, M. A., Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma. Blood 2004. 103: 1755-1762.
34. high regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J. Immunol. 2004. 173: 1444-1453.
35. + T cells: a common basis between tumor immunity and autoimmunity. J. Immunol. 1999. 163: 5211-5218.
36. Bruder, D., Probst-Kepper, M., Westendorf, A. M., Geffers, R., Beissert, S., Loser, K., von Boehmer, H., Buer, J. and Hansen, W., Neuropilin-1: a surface marker of regulatory T cells. Eur. J. Immunol. 2004. 34: 623-630.
37. Lennon, G. G., Auffray, C., Polymeropoulos, M. and Soares, M. B., The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression. Genomics 1996. 33: 151-152.
38. Karube, K., Ohshima, K., Tsuchiya, T., Yamaguchi, T., Kawano, R., Suzumiya, J., Utsunomiya, A., Harada, M. and Kikuchi, M., Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukemia/lymphoma cells. Br. J. Haematol. 2004. 126: 81-84.
39. high regulatory cells in human peripheral blood. J. Immunol. 2001. 167: 1245-1253.
40. Chang, C. C., Ciubotariu, R., Manavalan, J. S., Yuan, J., Colovai, A. I., Piazza, F., Lederman, S., Colonna, M., Cortesini, R., Dalla-Favera, R. and Suciu-Foca, N., Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immunol. 2002. 3: 237-243.
41. - T cells in an autoimmune disease model. J. Clin. Invest. 2003. 112: 1037-1048.
42. - T cells. Int. Immunol. 1998. 10: 775-783.
43. - regulatory T cells. J. Immunol. 1998. 161: 5193-5202.
44. - T cells. Transplantation 2000. 69: 1304-1310.
45. Li, J., Liu, Z., Jiang, S., Cortesini, R., Lederman, S. and Suciu-Foca, N., T suppressor lymphocytes inhibit NF-κB-mediated transcription of CD86 gene in APC. J. Immunol. 1999. 163: 6386-6392.
46. Xystrakis, E., Dejean, A. S., Bernard, I., Druet, P., Liblau, R., Gonzalez-Dunia, D. and Sauodi, A., Identification of a novel natural regulatory CD8T cell subset and analysis of its mechanism of regulation. Blood 2004. 104: 3294-3301.
47. - T cells. J. Clin. Invest. 2003. 112: 1437-1443.
48. + tolerogenic endothelial cells, inhibiting alloreactivity. Int. Immunol. 2004. 16: 1055-1068.
49. + T cell effector function. J. Immunol. 2003. 171: 1216-1223.
50. + T regulatory cells in humans. Hum. Immunol. 2005. 66: 13-20.
51. Mason, D. Y., Cordell, J. L. and Pulford, K. A. F., Production of monoclonal antibodies for immunocytochemical use. In Bullock, G. R. and Petrusz, P. (Eds.) Techniques in Immunocytochemistry. Academic Press, London 1983, pp 175-216.
52. Biddolph, S. C. and Gatter, K., Immunohistochemistry of lymphoid organs. In Rowland-Jones, S. L. and McMichael, A. J. (Eds.) Lymphocytes: A Practical Approach. Oxford University Press, Oxford 2000, pp 27-54.
53. Banham, A. H., Beasley, N., Campo, E., Fernandez, P. L., Fidler, C., Gatter, K., Jones, M., Mason, D. Y., Prime, J. E., Trougouboff, P. et al., The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p. Cancer Res. 2001. 61: 8820-8829.
54. Banham, A. H., Connors, J. M., Brown, P. J., Cordell, J. L., Ott, G., Sreenivasan, G., Farinha, P., Horsman, D. E. and Gascoyne, R., Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma. Clin. Cancer Res. 2005. 11: 1065-1072.
55. Erber, W. N., Pinching, A. J. and Mason, D. Y., Immunocytochemical detection of T and B cell populations in routine blood smears. Lancet 1984. 1: 1042-1046.
56. Marafioti, T., Jones, M., Facchetti, F., Diss, T. C., Du, M.-Q., Isaacson, P. G., Pozzobon, M., Pileri, S. A., Strickson, A., Watkins, F. and Mason, D. Y., Phenotype and genotype of interfollicular large B cells, a subpopulation of lymphocytes often with dendritic morphology. Blood 2003. 102: 2868-2876.
57. Dunbar, P. R., Ogg, G. S., Chen, J., Rust, N., van der Bruggen, P. and Cerundolo, V., Direct isolation, phenotyping and cloning of low-frequency antigen specific cytotoxic T lymphocytes from peripheral blood. Curr. Biol. 1998. 8: 413-416.
58. Nagvekar, N., Moody, A. M., Moss, P., Roxanis, I., Curnow, J., Beeson, D., Pantic, N., Newsom-Davis, J., Vincent, A. and Willcox, N. A., A pathogenic role for the thymoma in myasthenia gravis: autosensitisation of IL4 producing T cell clones recognising extracellular acetylcholine receptor epitopes presented by minority class II isotypes. J. Clin. Invest. 1998. 101: 2268-2277.